GBD has extended its partnership with Bio-Rad for dPCR to further develop innovative technology that enables ultra-sensitive nucleic acid detection and absolute quantification. This fall, we will present our findings in lectures and share them with our network. Some control samples have already been analyzed using dPCR, and we plan to increasingly use quantified materials in the future. This brings us closer to our goal of contributing to standardization in laboratory diagnostics.